The epidemiology of parkinson's disease in an Australian population

Neuroepidemiology

Volumn 17, Issue 6, 1998, Pages 310-317

  McCann, Sally J ^a   LeCouteur, David G ^b   Green, Adele C ^c   Brayne, Carol ^d   Johnson, Anthony G ^a   Chan, Daniel ^e   McManus, Michael E ^a   Pond, Susan M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e PRINCE HENRY HOSPITAL   (Australia)

Author keywords

Australia; Epidemiology; Parkinson's disease; Prevalence; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; DEPRESSION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; FLUID INTAKE; GENETIC SUSCEPTIBILITY; HEAD INJURY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; RISK FACTOR; SMOKING; STROKE;

AGE OF ONSET; AGED; ANALYSIS OF VARIANCE; AUSTRALIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; RISK FACTORS;

EID: 0031758532     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026185     Document Type: Article

References (40)

1. Tanner CM: The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci 1989;12(2);49-54.
2. Schoenberg BS, Osuntokun BO, Adeuja AOG, et al: Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies. Neurology 1988;38:645-646.
3. Zhang ZX, Roman GC: Worldwide occurrence of Parkinson's disease: An updated review. Neuroepidemiology 1993;12:195-208.
4. Tandberg E, Larsen JP, Nessler EG, Ruse T, Aarli JA: The epidemiology of Parkinson's disease in the county of Rogalund, Norway. Mov Disord 1995;10:541-549.
5. Ketzoian C, Chouza C, et al: Estudio pilote prevalencia de las principales enfermedadesneurologicas en una poblacion semirural del Uruguay. Proc 5th Panam Symp Neuroepidemiol, Montevideo, 1991.
6. Melcon MO, Andersen DW, Vergara RH. Rocca WA: Prevalence of Parkinson's disease in Junin, Buenos Aires Province, Argentina. Mov Disord 1997;12:197-205.
7. Jenkins AC: Epidemiology of parkinsonism in Victoria. Med J Aust 1966:ii:496-502.
8. Green A, Battistutta D, Hart V, et al: Nambour skin cancer and actinic eye disease prevention trial: Design and baseline characteristics of participants. Controlled Clin Trials 1994;15:512-522.
9. Calne DB, Snow BJ, Lee C: Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-S127.
10. Rajput AH, Uitti RJ, Stern W, Laverty W: Early onset Parkinson's disease in Saskatchewan - Environmental considerations for etiology, Can J Neurol Sci 1986;13:312-316.
11. Koller W, Vetere-Overfield B, Gray C, et al: Environmental risk factors in Parkinson's disease. Neurology 1990;40:1218-1221.
12. Semchuk KM, Love EJ, Lee RG: Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 1992;42: 1328-1335.
13. Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldan S: Exposure to well water and pesticides in Parkinson's disease: A case-control study in the Madrid area. Mov Disord 1992;7: 149-152.
14. Butterfield PG, Valanis BG, Spencer PS, Lindeman CA, Nutt JG: Environmental antecedents of young onset Parkinson's disease. Neurology 1993;43:1150-1158.
15. Hubble JP, Cao T, Hassanein RES, Neuberger JS, Koller WC: Risk factors for Parkinson's disease. Neurology 1993;43:1693-1697.
16. Tanner CM, Goldman SM: Epidemiology of movement disorders. Curr Opin Neurol Neurosurg 1994; 7:340-345.
17. Dias JA, Felgueiras MN, Sanchez JP, Goncalves JM, Falcao JM, Pimenta ZP: The prevalence of Parkinson's disease in Portugal: A population approach. Eur J Epidemiol 1994;10:763-767.
18. Wang SJ, Fun JL, Teng EL, Liu CY, Lin KP, Chen HM, Lin CH, Wang PN, Ting VC, Wang HC, Lin KN, Chou P, Larson EB, Liu HC: A door to door survey of Parkinson's disease in a Chinese population in Kinmen. Arch Neurol 1996;53(1):66-71.
19. Dumas M, Munoz M, Butros-Toni F, Vallet JM, Decouty J, Nao D, Jaubertau MO, Nazanga E: Neuroepidemiological study in Limousin (France). J Neurol 1985;232(suppl): 76.
20. Rocca WA, Anderson DW, Meneghini F, Grigoletto F, Morgante L, Reggio A, Savettieiri G, Di-Perri R: Occupation, education and Parkinson's disease: A case-control study in an Italian population. Mov Disord 1996;11:201-206.
21. De Michele G, Filla A, Volpe G, DeMarco V, Gogliettino A, Ambrosio G, Marconi R, Castellano AE, Campanella G: Environmental and genetic risk factors in Parkinson's disease: A case-control study in southern Italy. Mov Disord 1996; 11:17-23.
22. Mjones H: Paralysis agitans. A clinical genetic study. Acta Psychiatr Neurol Scand 1949;25(suppl 54):1-195.
23. Kondo K, Kurland LT, Schull WJ: Parkinson's disease: genetic analysis and evidence of a multifactorial etiology. Mayo Clin Proc 1973;48: 465-475.
24. Maraganore DM, Harding AE, Marsden CD: A clinical and genetic study of familial Parkinson's disease. Mov Disord 1991;6:205-211.
25. Semchuk KM, Love EJ, Lee RG: Parkinson's disease: A test of the multifactorial etiologic hypothesis. Neurology 1993;43:1173-1180.
26. Lazzarini AM, Myers RH, Zimmerman TR, et al: A clinical study of Parkinson's disease: Evidence for dominant transmission. Neurology 1994;44:499-506.
27. Payami H, Bernard S, Larsen K, Kaye J, Nutt J: Genetic anticipation in Parkinson's disease. Neurology 1995;45:135-138.
28. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC: A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990;27:276-282.
29. Wsolek ZK, Pfeiffer RN, Fulgham JR, et al: Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995;45:502-505.
30. Markopoulou K, Wszolek ZK, Pfeiffer RF: A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 1995;38: 373-378.
31. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC: Mapping a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274:1197-1198.
32. Bonifati V, Vanacore N, Meco G: Anticipation of onset age in familial Parkinson's disease. Neurology 1994;44:1978-1979.
33. Grandinetti A, Morens DM, Reed D, MacEachern D: Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994;139:1129-1138.
34. Morens DM, Grandinetti A, Reed D, White LR, Ross GW: Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology 1995; 45:1041-1051.
35. Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Ulm G, Schneider E: Possible environmental, occupational and other etiologic factors for Parkinson's disease: A case control study in Germany. Neurology 1996; 46:1275-1284.
36. Mayeux R, Tang M, Marder K, Cote LJ, Stern Y: Smoking and Parkinson's disease. Mov Disord 1994;9: 207-212.
37. Dyken M, Wolf P, Barnett H, Bergan JJ, Hass WK, Kannel WB, Kuller L, Kurtzke JF, Sundt TM: Risk factors in stroke: A statement for physicians for the subcommittee on risk factors and stroke of the Stroke council. Stroke 1984;15:1105-1111.
38. Richards M, Chaudhuri KR: Parkinson's disease in populations of African origin: A review. Neuroepidemiology 1996;15:214-221.
39. Struck LK, Rodnitzky RL, Dobson JK: Stroke and its modification in Parkinson's disease. Stroke 1990;21: 1395-1399.
40. Levine RL, Jones JC, Bee N: Stroke and Parkinson's disease. Stroke 1992;23:839-842.